North America Ocular Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, and Others), Formulation Type (Liposomes and Nanoparticles, Solution, Emulsion, Suspension, and Ointment), Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, and Others), and End User (Hospitals, Ophthalmic Clinics, and Ambulatory Surgical Centers)

Name: North America Ocular Drug Delivery Market
SKU: Pharmaceuticals
Rating: 4.8 (18 reviews)

Market Introduction

The North America ocular drug delivery market has been segmented into the US, Canada, and Mexico. The US holds the largest share of the North America ocular drug delivery market. In North America, the US holds a significant share of the ocular drug delivery market. The growth of the market in the US is primarily driven by product awareness and the increasing prevalence of eye diseases. Further, the aging population in the US is likely to increase the incidence of eye diseases, which will eventually drive the adoption of ocular drug delivery products in the country. For instance, as per the Population Reference Bureau 2019, the number of individuals in the US aged 65 and older is estimated to double from 52 million in 2018 to around 95 million by 2060, and the 65 and more age group’s share of the total population will increase from 16% to 23%. This aged population is highly vulnerable to eye conditions. For instance, as per the American Academy of Ophthalmology 2019 study, an estimated 7.32 million people aged 70-75 are affected by primary open-angle glaucoma (POAG) by 2050 in the US.

Amidst the COVID-19 crisis, the healthcare institutions have witnessed decrees in inpatient visits to clinics to prevent the spread of the COVID-19 in the first and second quarters of 2020. As per the recent study by CDC, the number of medical emergency department (ED) visits has declined 42% during the early COVID-19. As a result, the number of elective eye procedures performed per week in hospitals and clinics has decreased over time. According to an article in Ophthalmology Times, elective procedures have decreased in countries such as the United States. The number of patient visits to examination facilities has reduced by 15%. During the COVID-19 pandemic, ophthalmology lost a considerable share of patient volume; the volume of ophthalmic practice is predicted to have decreased by 81%, owing to a decline in patients seeking care for glaucoma and cataracts surgery.

Get more information on this report :

Market Overview and Dynamics

The ocular drug delivery market in North America is expected to grow US$ 10,622.77 million by 2028 from US$ 6,286.54 million in 2021. The market is estimated to grow at a CAGR of 7.8% from 2021 to 2028. Several players operating in the ocular drug delivery market are developing and launching innovative products. The strategy of development and launch of new products helps companies to cater to a broad customer base. For instance, in June 2020, Senju Pharmaceutical Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. announced the launch of a new combination ophthalmic solution, AILAMIDE Combination Ophthalmic Suspension, for the treatment of glaucoma and ocular hypertension. Similarly, in October 2019, Sun Pharmaceutical Industries launched the ophthalmic solution Cequa in the US, which is used to treat dry-eye disease. Additionally, in May 2019, Menicon Co., Ltd launched Menicon Bloom Myopia Control Management System. Menicon Bloom Night therapy includes the overnight wearing of a specifically designed reverse geometry orthokeratology contact lens—manufactured in hyper oxygen-permeable Menicon Z rigid material that guarantees ideal corneal oxygenation for comfortable contact lens wear. Additionally, in January 2019, Ocular Therapeutix launched Dextenza (dexamethasone ophthalmic insert) 0.4 mg in the US to treat ocular inflammation and pain following ophthalmic surgery. Dextenza received FDA approval in November 2018 for the treatment of ocular pain following ophthalmic surgery. Such developments and launches of new products are emerging as a key trend in the ocular drug delivery market.

Key Market Segments

North America ocular drug delivery market is segmented based on technology, formulation type, disease type, end user. Based on technology, implantable ocular drug delivery systems segment accounted for the highest share in 2021. Based on formulation type, solution segment accounted for the highest share in 2021. Based on disease type, cataract segment accounted for the highest share in 2021. Based on end user hospitals segment accounted for the highest share in 2021.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on ocular drug delivery market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are AbbVie Inc.; Bausch Health Companies Inc.; Novartis AG; Clearside Biomedical, Inc.; Ocular Therapeutix, Inc.; Envisia Therapeutics; Alimera Sciences, Inc.; EYEGATE PHARMACEUTICALS, INC. among others.

Reasons to buy report

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America ocular drug delivery market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in North America ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

North America Ocular Drug Delivery Market Segmentation

North America Ocular Drug Delivery Market – By Technology

Implantable Ocular Drug Delivery Systems
Particulate Drug Delivery Systems
Nano-Particle Drug Delivery System
Others

North America Ocular Drug Delivery Market – By Formulation Type

Solution
Ointment
Suspension
Emulsion
Liposomes and Nanoparticles

North America Ocular Drug Delivery Market – By Disease type

North America Ocular Drug Delivery Market – By End User

Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers

North America Ocular Drug Delivery Market – By Country

US
Canada
Mexico

North America Ocular Drug Delivery Market – Companies Mentioned

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Ocular Drug Delivery Market – By Technology

1.3.2 North America Ocular Drug Delivery Market – By Formulation Type

1.3.3 North America Ocular Drug Delivery Market – By Disease Type

1.3.4 North America Ocular Drug Delivery Market – By End User

1.3.5 North America Ocular Drug Delivery Market – By Country

2. North America Ocular Drug Delivery Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Ocular Drug Delivery – Market Landscape

4.1 Overview

4.2 Expert Opinions

5. North America Ocular Drug Delivery Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Elevating Prevalence of Eye Disorders

5.2 Market Restraints

5.2.1 Limitations Associated with Ocular Drug Delivery

5.3 Market Opportunities

5.3.1 Expansion Awareness About Vision Care

5.4 Future Trends

5.4.1 Thriving of Innovative Products

5.5 Impact analysis

6. North America Ocular Drug Delivery – Market Analysis

6.1 North America Ocular Drug Delivery Market Revenue Forecast and Analysis

7. North America Ocular Drug Delivery Market Analysis – By Technology

7.1 Overview

7.2 North America Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

7.3 Implantable Ocular Drug Delivery Systems

7.3.1 Overview

7.3.2 Implantable Ocular Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.4 Particulate Drug Delivery Systems

7.4.1 Overview

7.4.2 Particulate Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.5 Nano-Particle Drug Delivery System

7.5.1 Overview

7.5.2 Nano-Particle Drug Delivery System Market Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. North America Ocular Drug Delivery Market Analysis – By Formulation Type

8.1 Overview

8.1.1 North America Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

8.2 Liposomes and Nanoparticles Market

8.2.1 Overview

8.2.2 Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

8.3 Solution

8.3.1 Overview

8.3.2 Solution Market Revenue and Forecasts to 2028 (US$ Million)

8.4 Emulsion

8.4.1 Overview

8.4.2 Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

8.5 Suspension

8.5.1 Overview

8.5.2 Suspension Market Revenue and Forecasts to 2028 (US$ Million)

8.6 Ointment

8.6.1 Overview

8.6.2 Ointment Market Revenue and Forecasts to 2028 (US$ Million)

9. North America Ocular Drug Delivery Market Analysis – By Disease Type

9.1 Overview

9.2 North America Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

9.3 Cataract

9.3.1 Overview

9.3.2 Cataract Market Revenue and Forecast to 2028 (US$ Million)

9.4 Dry Eye Syndrome

9.4.1 Overview

9.4.2 Dry Eye Syndrome Market Revenue and Forecast to 2028 (US$ Million)

9.5 Macular Degeneration

9.5.1 Overview

9.5.2 Macular Degeneration Market Revenue and Forecast to 2028 (US$ Million)

9.6 Glaucoma

9.6.1 Overview

9.6.2 Glaucoma Market Revenue and Forecast to 2028 (US$ Million)

9.7 Diabetic Retinopathy

9.7.1 Overview

9.7.2 Diabetic Retinopathy Market Revenue and Forecast to 2028 (US$ Million)

9.8 Diabetic Macular Edema

9.8.1 Overview

9.8.2 Diabetic Macular Edema Market Revenue and Forecast to 2028 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. North America Ocular Drug Delivery Market Analysis – By End User

10.1 Overview

10.2 Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.4 Ophthalmic Clinics

10.4.1 Overview

10.4.2 Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.5 Ambulatory Surgical Centers

10.5.1 Overview

10.5.2 Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

11. North America Ocular Drug Delivery Market – Country Analysis

11.1 Overview

11.1.1 North America: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)

11.1.1.1 US: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.1 US: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.2 US Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.3 US: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.4 US: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.5 US: Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.1.2 Canada: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.1 Canada: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.2 Canada Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.3 Canada Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.4 Canada Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.5 Canada Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.1.3 Mexico: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.1 Mexico: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.2 Mexico Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.3 Mexico Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.4 Mexico Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.5 Mexico Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

12. Impact Of COVID-19 Pandemic on North America Ocular Drug Delivery Market

12.1 Impact Assessment of COVID-19 Pandemic

13. Industry Landscape

13.1 Overview

13.2 Organic Developments

13.2.1 Overview

13.3 Inorganic Developments

13.3.1 Overview

14. Company Profiles

14.1 AbbVie Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Bausch Health Companies Inc.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Ocular Therapeutix, Inc.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Alimera Sciences, Inc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Envisia Therapeutics

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Novartis AG

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 EYEGATE PHARMACEUTICALS, INC

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Clearside Biomedical, Inc.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. US Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 2. US Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (USD Million)

Table 3. US Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)

Table 4. US Ocular Drug Delivery Market, by End User- Revenue and Forecast to 2028 (USD Million)

Table 5. Canada Ocular Drug Delivery Market, by Technology -Revenue and Forecast to 2028 (USD Million)

Table 6. Canada Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (USD Million)

Table 7. Canada Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 8. Canada Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. Mexico Ocular Drug Delivery Market, by Technology -Revenue and Forecast to 2028 (USD Million)

Table 10. Mexico Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (USD Million)

Table 11. Mexico Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 12. Mexico Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Organic Developments Done By Companies

Table 14. Inorganic Developments Done by Companies

Table 15. Glossary of Terms, Ocular Drug Delivery Market

LIST OF FIGURES

Figure 1. North America Ocular Drug Delivery Market Segmentation

Figure 2. North America Ocular Drug Delivery Market Segmentation, By Country

Figure 3. North America Ocular Drug Delivery Market Overview

Figure 4. Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market

Figure 5. The US to Show Significant Growth During Forecast Period

Figure 6. North America Ocular Drug Delivery Market, Industry Landscape

Figure 7. North America PEST Analysis

Figure 8. North America Ocular Drug Delivery Market Impact Analysis of Driver and Restraints

Figure 9. North America Ocular Drug Delivery Market – Revenue Forecast and Analysis – 2020- 2028

Figure 10. North America Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

Figure 11. Implantable Ocular Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Particulate Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Nano-Particle Drug Delivery System Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. North America Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

Figure 16. Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Solution Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Suspension Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Ointment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. North America Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

Figure 22. Cataract Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Dry Eye Syndrome Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Macular Degeneration Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Glaucoma Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Diabetic Retinopathy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Diabetic Macular Edema Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

Figure 30. Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 32. Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 33. North America: Ocular Drug Delivery Market, by Key Country – Revenue (2021) (USD Million)

Figure 34. North America: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)

Figure 35. US: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 36. Canada: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 37. Mexico: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 38. Impact of COVID-19 Pandemic in North American Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America ocular drug delivery market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in North America ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample